ReviewMolecular diversity2022

Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries.

Chandrabose Selvaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.